pd-166793 Search Results


pd-166793  (MedChemExpress)
N/A
PD-166793 is a potent, selective, orally active and wide-broad spectrum inhibitor of MMP, exhibiting nanomolar potency against MMP-2, MMP-3 and MMP-13 (IC50=4, 7, and 8 nM, respectively) and micromolar potency vs MMP-1, -7 and -9
   Buy from Supplier
pd166793  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology pd166793
Pd166793, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-166793/PD166793/pm23175708-213-9-10
Average 92 stars, based on 1 article reviews
pd166793 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier
broad spectrum mmp inhibitor pd166793  (Tocris)
93
Tocris broad spectrum mmp inhibitor pd166793
Broad Spectrum Mmp Inhibitor Pd166793, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-166793/PD+166793/pm23830916-79-13-17
Average 93 stars, based on 1 article reviews
broad spectrum mmp inhibitor pd166793 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
pd166793  (Tocris)
93
Tocris pd166793
BMP9-induced collagen remodelling is repressed by the MMP inhibitor <t>PD166793.</t> (A) Histogram describing the total loss over 21 days of sGAG to the medium from explants (n = 6, ANOVA, post hoc Tukey ). Mean ± SD. (B) Total sGAG loss to the medium over 21 days in control and BMP9 (100 ng mL -1 )-cultured explants with or without 10 or 100 μM PD166793 (n = 6). Mean ± SD. (C) Toluidine blue staining, picrosirius red staining, and polarised light microscopy of control and BMP9-cultured explants cultured for 21 days with or without the stated concentrations of PD166793. Bar = 200 μm. Data representative of explants extracted from three different donors. Note the failure of BMP9-cultured explants to partially and completely undergo collagen remodelling when exposed to PD166793; under PLM, collagen fibrils are aligned parallel to the surface, and toluidine staining indicates minimal proteoglycan loss.
Pd166793, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-166793/PD+166793/pmc11810917-227-3-4
Average 93 stars, based on 1 article reviews
pd166793 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
pan mmp inhibitor pd166793  (AnaSpec)
90
AnaSpec pan mmp inhibitor pd166793
BMP9-induced collagen remodelling is repressed by the MMP inhibitor <t>PD166793.</t> (A) Histogram describing the total loss over 21 days of sGAG to the medium from explants (n = 6, ANOVA, post hoc Tukey ). Mean ± SD. (B) Total sGAG loss to the medium over 21 days in control and BMP9 (100 ng mL -1 )-cultured explants with or without 10 or 100 μM PD166793 (n = 6). Mean ± SD. (C) Toluidine blue staining, picrosirius red staining, and polarised light microscopy of control and BMP9-cultured explants cultured for 21 days with or without the stated concentrations of PD166793. Bar = 200 μm. Data representative of explants extracted from three different donors. Note the failure of BMP9-cultured explants to partially and completely undergo collagen remodelling when exposed to PD166793; under PLM, collagen fibrils are aligned parallel to the surface, and toluidine staining indicates minimal proteoglycan loss.
Pan Mmp Inhibitor Pd166793, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-166793/pan+mmp+inhibitor+pd166793/pmc04312249-74-7-11
Average 90 stars, based on 1 article reviews
pan mmp inhibitor pd166793 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
pd166793  (Pfizer Inc)
86
Pfizer Inc pd166793
BMP9-induced collagen remodelling is repressed by the MMP inhibitor <t>PD166793.</t> (A) Histogram describing the total loss over 21 days of sGAG to the medium from explants (n = 6, ANOVA, post hoc Tukey ). Mean ± SD. (B) Total sGAG loss to the medium over 21 days in control and BMP9 (100 ng mL -1 )-cultured explants with or without 10 or 100 μM PD166793 (n = 6). Mean ± SD. (C) Toluidine blue staining, picrosirius red staining, and polarised light microscopy of control and BMP9-cultured explants cultured for 21 days with or without the stated concentrations of PD166793. Bar = 200 μm. Data representative of explants extracted from three different donors. Note the failure of BMP9-cultured explants to partially and completely undergo collagen remodelling when exposed to PD166793; under PLM, collagen fibrils are aligned parallel to the surface, and toluidine staining indicates minimal proteoglycan loss.
Pd166793, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-166793/pd166793/pm20675565-50-10-11
Average 86 stars, based on 1 article reviews
pd166793 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
pd 166793  (BOC Sciences)
N/A
PD 166793 is a broad-spectrum matrix metalloproteinase (MMP) inhibitor (IC50s = 6.1, 0.047, 0.012, 7.2, 7.9, 0.008, and 0.24 μM for MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13CD, and MMP-14CD, respectively). It displays high affinity for
   Buy from Supplier
pd-166793  (TargetMol)
N/A
   Buy from Supplier
pd166793  (MuseChem Chemicals)
N/A
   Buy from Supplier
pd 166793  (Cayman Chemical)
N/A
PD 166793
   Buy from Supplier
pd 166793  (Toronto Research Chemicals)
N/A
   Buy from Supplier
mmp-2/mmp-3 inhibitor iii, pd166793  (Biosynth Carbosynth)
N/A
   Buy from Supplier

Image Search Results


BMP9-induced collagen remodelling is repressed by the MMP inhibitor PD166793. (A) Histogram describing the total loss over 21 days of sGAG to the medium from explants (n = 6, ANOVA, post hoc Tukey ). Mean ± SD. (B) Total sGAG loss to the medium over 21 days in control and BMP9 (100 ng mL -1 )-cultured explants with or without 10 or 100 μM PD166793 (n = 6). Mean ± SD. (C) Toluidine blue staining, picrosirius red staining, and polarised light microscopy of control and BMP9-cultured explants cultured for 21 days with or without the stated concentrations of PD166793. Bar = 200 μm. Data representative of explants extracted from three different donors. Note the failure of BMP9-cultured explants to partially and completely undergo collagen remodelling when exposed to PD166793; under PLM, collagen fibrils are aligned parallel to the surface, and toluidine staining indicates minimal proteoglycan loss.

Journal: Frontiers in Cell and Developmental Biology

Article Title: BMP9 induces postnatal zonal stratification of immature articular cartilage through reconfiguration of the existing collagen framework

doi: 10.3389/fcell.2024.1511908

Figure Lengend Snippet: BMP9-induced collagen remodelling is repressed by the MMP inhibitor PD166793. (A) Histogram describing the total loss over 21 days of sGAG to the medium from explants (n = 6, ANOVA, post hoc Tukey ). Mean ± SD. (B) Total sGAG loss to the medium over 21 days in control and BMP9 (100 ng mL -1 )-cultured explants with or without 10 or 100 μM PD166793 (n = 6). Mean ± SD. (C) Toluidine blue staining, picrosirius red staining, and polarised light microscopy of control and BMP9-cultured explants cultured for 21 days with or without the stated concentrations of PD166793. Bar = 200 μm. Data representative of explants extracted from three different donors. Note the failure of BMP9-cultured explants to partially and completely undergo collagen remodelling when exposed to PD166793; under PLM, collagen fibrils are aligned parallel to the surface, and toluidine staining indicates minimal proteoglycan loss.

Article Snippet: For inhibitor studies, PD166793 (Tocris, UK), dissolved in dimethyl sulphoxide (DMSO), was added at a final concentration of either 10 μM or 100 μM to explant medium, with control explants receiving the same volume of DMSO.

Techniques: Control, Cell Culture, Staining, Light Microscopy